C4 Therapeutics (CCCC) Other Working Capital Changes (2019 - 2026)
C4 Therapeutics (CCCC) posted quarterly Other Working Capital Changes of -$1.5 million for Q1 2026, down 6007.69% year-over-year from $26000.0 in Q1 2025, and up 73.75% quarter-over-quarter from -$5.9 million in Q4 2025.
C4 Therapeutics (CCCC) Other Working Capital Changes (2019 - 2026) Analysis & Trends
C4 Therapeutics' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$1.5 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 6007.69% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$7.3 million (down 669.57% YoY), while the FY2025 annual figure was -$5.8 million, down 96333.33% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$1.5 million, up from -$5.9 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $20.9 million in Q4 2022, with the low at -$15.7 million in Q2 2022.
- The 5-year median for Other Working Capital Changes is -$2.3 million (2024), against an average of -$2882.4.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes soared 4925.0% in 2024, then plunged 12351.06% in 2025.
- C4 Therapeutics' Other Working Capital Changes stood at -$575000.0 in 2022, then soared by 92.52% to -$43000.0 in 2023, then retreated by 9.3% to -$47000.0 in 2024, then slumped by 12351.06% to -$5.9 million in 2025, then soared by 73.75% to -$1.5 million in 2026.
- Business Quant data shows CCCC's Other Working Capital Changes at -$1.5 million in Q1 2026, -$5.9 million in Q4 2025, and $2.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | C4 Therapeutics | 521.12 Mn | 267.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.81 Mn |
| Jun 30, 2026 | 14.81 Mn |
| Jun 30, 2026 | 14.81 Mn |
| Mar 31, 2026 | -122,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Mar 31, 2026 | -122,000.00 |
| Dec 31, 2025 | 9.01 Mn |
| Dec 31, 2025 | 9.01 Mn |
| Dec 31, 2025 | 9.01 Mn |
| Sep 30, 2025 | -6.18 Mn |
| Sep 30, 2025 | -6.18 Mn |
| Sep 30, 2025 | -6.18 Mn |
| Jun 30, 2025 | -3.63 Mn |
| Jun 30, 2025 | -3.63 Mn |
| Jun 30, 2025 | -3.63 Mn |
| Mar 31, 2025 | -341,000.00 |
| Mar 31, 2025 | -341,000.00 |
| Mar 31, 2025 | -341,000.00 |
| Dec 31, 2024 | -7.81 Mn |
| Dec 31, 2024 | -7.81 Mn |